Aspirin and statin medication decreases the risk of myocardial infarction associated with LTA and NFKBIL1 polymorphisms
Höyssä Salla,
Rontu Riikka,
Kuukasjärvi Pekka,
Mennander Ari,
Laurikka Jari,
Tarkka Matti,
Nikus Kjell,
Islam Md.,
Karhunen Pekka,
Lehtimäki Terho
Affiliations
Höyssä Salla
Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, University of Tampere, Medical School and Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland
Rontu Riikka
Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, University of Tampere, Medical School and Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland
Kuukasjärvi Pekka
Mennander Ari
Laurikka Jari
Heart Centre Department of Cardio-thoracic Surgery, Tampere University Hospital and Tampere University Medical School, Tampere, Finland
Tarkka Matti
Heart Centre Department of Cardio-thoracic Surgery, Tampere University Hospital and Tampere University Medical School, Tampere, Finland
Nikus Kjell
Heart Centre Department of Cardiology, Tampere University Hospital, Tampere, Finland
Islam Md.
Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, University of Tampere, Medical School and Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland
Karhunen Pekka
Department of Forensic Medicine, University of Tampere, Medical School and Research Unit of the Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland
Lehtimäki Terho
Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, University of Tampere, Medical School and Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland
